Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years

Conditions

• Smallpox
• Monkeypox
• Cowpox
• Vaccinia Virus Infection

Interventions

• BIOLOGICAL: VAC∆6 vaccine (10⁷ PFU)
• BIOLOGICAL: VAC∆6 vaccine (10⁶ PFU)
• BIOLOGICAL: Live Smallpox Vaccine
• OTHER: Placebo (Sodium chloride bufus, 0.9%)

Sponsor

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"